iShares IV plc (IIND) MSCI India UCITS ETF USD Acc (GBP)

Sell:£7.19Buy:£7.20£0.02 (0.26%)

Prices delayed by at least 15 minutes
Sell:£7.19
Buy:£7.20
Change:£0.02 (0.26%)
Prices delayed by at least 15 minutes
Sell:£7.19
Buy:£7.20
Change:£0.02 (0.26%)
Prices delayed by at least 15 minutes

ETF Information

Objective

The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the MSCI India Index Net USD, the Fund’s benchmark index (Index). The Share Class, via the Fund, invests in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index. The Index measures the performance of large and mid capitalisation stocks of the Indian market, which are subject to MSCI’s size, liquidity and free-float criteria. The Index is a free float-adjusted market capitalisation weight index and rebalances on a quarterly basis. Free float-adjusted means that only shares readily available in the market rather than all of a company’s issued shares are used in calculating the Index. Free float-adjusted market capitalisation is the share price of a company multiplied by the number of shares readily available in the market. Securities that are liquid means that they can be easily bought or sold in the market in normal market conditions. The Fund intends to replicate the Index by holding the equity securities, which make up the Index, in similar proportions to it. The investment manager may use financial derivative instruments (FDIs) (i.e. investments the prices of which are based on, one or more underlying assets) to help achieve the Fund’s investment objective. FDIs may be used for direct investment purposes. Your shares will be accumulating shares (i.e. income will be included in their value).

  • Leverage -
  • Currency hedgingNo

Costs

  • Ongoing Charge (OCF/TER)0.65%
  • Management fee -
  • Indicative spread0.06%

Replication

  • Replication method -
  • Rebalancing frequency -
  • Number of holdings164
  • How is collateral used? -

Securities lending

  • Is stock lending permitted?No
  • Is stock currently being lent?No
  • Maximum that can be lent -
  • 12 month average % on loan -
  • 12 month return from stock lending -
  • Gross revenue returned -

Counterparties

  • Issuer -
  • Investment Manager -
  • Trustee -
  • Custodian -

Value Assessment

  • Value Assessment review date31 March 2025
  • Value Assessment next review date -
  • Is Assessment of Value required under COLL?No
  • Outcome of COLL Assessment of Value -
  • Outcome of PRIN Value Assessment or reviewProduct expected to provide fair value for reasonably foreseeable period
  • Other review related to value and or charges -
  • Further information-

Key facts

  • Issuer
    -
  • Structure
    ETF
  • Number of holdings
    164
  • Size
    $5.52bn
  • Launch date
    24 May 2018
  • Launch price
    -
  • UCITS
    No
  • Reporting status
    -
  • Domicile
    Ireland
  • ISIN
    IE00BZCQB185

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data provided by Broadridge. Some of the data on this page and other related pages is provided to you for your information and is received from the Fund Management Company administering this fund. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties. Securities lending data correct as at 02 March 2018. Charge data correct as at date not available. Holdings correct as at 30 September 2024. News service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see Digital Look Ltd Copyright Notice - Sharecast.com for our terms and conditions.